Concepedia

Wendy Tomlinson

WT

Statistics

Publications

13

Citations

1.2K

H-Index

12

Active since

1990

Affiliations

Loughborough University(Current)

AstraZeneca (United Kingdom)

AstraZeneca (Brazil)

Research & Development Institute

Loughborough College

Wendy Tomlinson is an author at Loughborough University specializing in pharmacology, medicine, and platelet activation.

Publications per year

1990–2013

13

Publications

13

Antagonists of the Platelet P<i><sub>2T</sub></i> Receptor: A Novel Approach to Antithrombotic Therapy

Anthony H. Ingall, John Dixon, Andrew Bailey et al. · Journal of Medicinal Chemistry · 1999 · 285 citations

Medicine, Medicinal Chemistry, Pharmacology +17

Ticagrelor binds to human P2Y12 independently from ADP but antagonizes ADP‐induced receptor signaling and platelet aggregation

J.J.J. van Giezen, Lena Nilsson, P. Berntsson et al. · Journal of Thrombosis and Haemostasis · 2009 · 279 citations

Medicine, Molecular Biology, Pharmacology +16

From ATP to AZD6140: The discovery of an orally active reversible P2Y12 receptor antagonist for the prevention of thrombosis

Brian Springthorpe, A. S. Bailey, Patrick Barton et al. · Bioorganic & Medicinal Chemistry Letters · 2007 · 235 citations · Full text

Medicine, Medicinal Chemistry, Pharmacology +12

FPL 66096: a novel, highly potent and selective antagonist at human platelet P<sub>2T</sub>‐purinoceptors

Robert G. Humphries, Wendy Tomlinson, Anthony H. Ingall et al. · British Journal of Pharmacology · 1994 · 98 citations · Full text

Medicine, Biochemistry, Pharmacology +15

Pharmacological profile of the novel P<sub>2</sub>T‐purinoceptor antagonist, FPL 67085 in vitro and in the anaesthetized rat in vivo

Robert G. Humphries, Wendy Tomlinson, J. A. Clegg et al. · British Journal of Pharmacology · 1995 · 49 citations · Full text

Medicine, Pharmacology, Experimental Pharmacology +14

1–5 of 13